Wexford Capital »

Cullinan Oncology shares owned by Wexford Capital

Quarter-by-quarter ownership of Cullinan Oncology (CGEM) shares owned by Wexford Capital from 13F filings

Historical chart of Wexford Capital investment in Cullinan Oncology

Tip: Access up to 7 years of quarterly data

All positions including Cullinan Oncology held by Wexford Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cullinan Oncology by Wexford Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $32k 5.3k 5.93
2025-06-30 $141k 19k 7.53

More positions owned by Wexford Capital

Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Mammoth Energy Svcs (TUSK)
Nephros (NEPH)
Core Natural Resources Com Shs (CNR)
EQT Corporation (EQT)
Chesapeake Energy Corp (EXE)
Energy Transfer Com Ut Ltd Ptn (ET)
Teekay Tankers Cl A (TNK)
Vaneck Etf Trust Semiconductr Etf Put Option (SMH)
Imperial Pete Com New (IMPP)
Acm Resh Com Cl A (ACMR)
Enterprise Products Partners (EPD)
Ishares Tr 20 Yr Tr Bd Etf Call Option (TLT)
Century Aluminum Company (CENX)
Antero Res (AR)

View all positions for Wexford Capital

Top funds holding Cullinan Oncology

MPM Oncology Impact Management
Lynx1 Capital Management
BVF
BlackRock
Vanguard Group
Deerfield Management Company
Blue Owl Capital Holdings
Kynam Capital Management
Citadel Advisors
OrbiMed Advisors
Rtw Investments
State Street Corporation
Franklin Resources
VR Adviser
Geode Capital Management

View all funds holding Cullinan Oncology